Usa India Denmark Finland Sweden covid-19 vaccine reports Usa India Denmark Finland Sweden

FDA delays decision on Moderna's Covid vaccine for adolescents: Report

Reading now: 245

Wall Street Journal reported on Friday, citing people familiar with the matter. Moderna's shares fell nearly 2% to $326.25 in midday trading after the report.

The US Food and Drug Administration (FDA) has been looking into the risk of myocarditis among younger men vaccinated with Moderna's shot, especially compared with Pfizer's vaccine, after certain Nordic countries limited use of the shot, the Wall Street Journal report said.

The agency has not yet determined whether there is heightened risk, the report added. Earlier this month, Finland, Sweden and Denmark paused the use of Moderna's Covid-19 shot for younger males due to reports of the side effect, myocarditis, in men.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News